Join us to unlock a new era of Neurotoxin. October 7, 2026, 8:00 – 9:30 PM EST.
Unlock a new era of neurotoxin: Introducing Boey
Join us to unlock a new era of Neurotoxin
October 7, 2026, 8:00 - 9:30 PM EST
|
|
|
At Allergan Medical Institute (AMI), we are committed to delivering credible, expert-led education in aesthetic medicine. Whether you are expanding your knowledge or refining your approach, we’re here to support your learning every step of the way.
With the official Canadian launch of Boey® (trenibotulinumtoxinE),
we invite you to join Unlock a New Era of Neurotoxin: Introducing Boey, a webinar offering an exclusive first look at Allergan Aesthetics’ newest innovation, Boey®. Boey® is the first and only type E botulinum neurotoxin approved for the temporary improvement in the appearance of moderate to severe glabellar lines.1
Be among the first in Canada to discover Boey® and learn from experts about this exciting new advancement and its potential to shape the future of aesthetic neurotoxin treatments.
Join us on October 7, 2026
8:00 – 9:30PM EST | 5:00-6:30 PM PST
|
|
|
|
SESSION HIGHLIGHTS
| • |
Explore the opportunities shaping the future of aesthetic neurotoxin treatments. |
| • |
Discover the science and clinical evidence behind Boey®. |
| • |
Gain practical insights into patient selection and considerations for supporting the treatment journey. |
|
|
|
|
Meet The Expert Faculty
|
|
|
Dr. Jean D. Carruthers is a Clinical Professor in the Department of Ophthalmology and Visual Sciences at the University of British Columbia in Vancouver, specializing in facial cosmetic injectables, energy-based devices including lasers, and cosmetic surgery. She is an internationally recognized leader in aesthetic medicine, with more than 400 peer-reviewed publications and numerous prestigious awards for her contributions to the field. |
|
| |
| Dr. Daniela Greiner-Krüger |
|
|
Dr. Daniela Greiner-Krüger is a board-certified dermatologist specializing in aesthetic dermatology, allergology, and phlebology, and owner of Medicorium, a leading aesthetic clinic in the Frankfurt region. An internationally recognized speaker and clinical researcher, she has extensive expertise in energy-based devices, laser medicine, dermatologic surgery, and aesthetic procedures. |
|
| |
|
|
Dr. Vince Bertucci is a cosmetic dermatologist and internationally recognized educator, serving as Co-Director of the Cosmetic Dermatology Fellowship at the University of Toronto and Founder & Medical Director of Bertucci Dermatology & MedSpa. A former President of both the ASDS and CDA, he is a respected clinical investigator, author, and speaker who has made significant contributions to the field of aesthetic and cosmetic dermatology. |
|
| |
|
|
Dr. Mitchell F. Brin is Senior Vice President, R&D and Chief Scientific Officer, BOTOX® & Neurotoxins at AbbVie and Allergan Aesthetics. He has led or contributed to the global development and licensure of BOTOX®, BOTOX® Cosmetic, trenibotulinumtoxinE, and next-generation neurotoxins and biologics. He is also a Clinical Professor of Neurology at the University of California, Irvine. |
|
| |
|
|
|
